{"id":"tp-51259","type":"article-newspaper","title":"LB Pharmaceuticals Posts $1.79 Loss Per Share in Third Quarter","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/51259","datePublished":"2026-11-08T01:49:16.000Z","dateModified":"2026-11-08T01:49:16.000Z","language":"en","abstract":"Research and development expenses rose to $51.516 million as the company advanced two clinical trials. It expects its $403.760 million in cash and investments to fund planned operations beyond the second quarter of 2029.","section":"Business","references":[]}